Inventor
Shawn Schiller
Inventor
Haverhill, MA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds26%
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides7%
C07CAcyclic or carbocyclic compounds4%
Y02PClimate change mitigation technologies in the production or processing of goods4%
C07BGeneral methods of organic chemistry3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
10,870,648Inhibiting CREB binding protein (CBP)202010,800,750Compounds and compositions for inhibition of FASN202010,703,764Benzopiperazine compositions as BET bromodomain inhibitors202010,640,500Tetrahydropyrazolopyrimidine compounds202010,611,750Tetrahydroquinoline compositions as bet bromodomain inhibitors202010,472,342Compounds and compositions for inhibition of FASN201910,457,655Compounds and compositions for inhibition of FASN201910,450,286Compounds and compositions for inhibition of FASN201910,399,951Compounds and compositions for inhibition of FASN201910,377,769Benzopiperazine compositions as BET bromodomain inhibitors201910,336,722Tetrahydroquinoline compositions as BET bromodomain inhibitors2019RE047193Selectively substituted quinoline compounds201910,087,174Selectively substituted quinoline compounds20189,850,242Tetrahydropyrazolopyrimidine compounds20179,663,486'Selectively substituted quinoline compounds'20179,446,046'Tetrahydropyrazolopyrimidine compounds'20169,428,495'Selectively substituted quinoline compounds'20169,422,281'Benzopiperazine compositions as BET bromodomain inhibitors'20169,388,161'Tetrahydroquinoline compositions as BET bromodomain inhibitors'20169,126,999'Tetrahydropyrazolopyrimidine compounds'20158,633,224'Hemiasterlin derivatives and uses thereof in the treatment of cancer'20148,129,407'Hemiasterlin derivatives and uses thereof in the treatment of cancer'20127,985,746'Imidazoazepinone compounds'20117,666,875'Hydantoin compounds'20107,585,976'Hemiasterlin derivatives and uses thereof'20097,528,152'Hemiasterlin derivatives and uses thereof in the treatment of cancer'20097,524,883'Eponemycin and epoxomicin analogs and uses thereof'20097,192,972'Hemiasterlin derivatives and uses thereof'20077,064,211'Hemiasterlin derivatives and uses thereof'2006Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2006–2014Patents assigned to EISAI CO LTD (5)· patent assignee history
2006–2020Based in Haverhill, MA, US· patent location history
2009–2020Patents assigned to EISAI R&D MAN CO LTD (11)· patent assignee history
2012–2015Patents assigned to SCHILLER SHAWN (3)· patent assignee history
2012–2014Patents assigned to KOWALCZYK JAMES J (2)· patent assignee history
2016–2020Patents assigned to FORMA THERAPEUTICS INC (12)· patent assignee history
2019–2020Based in Watertown, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| FORMA THERAPEUTICS INC | 12 | 2016–2020 |
| EISAI R&D MAN CO LTD | 11 | 2009–2020 |
| EISAI CO LTD | 5 | 2006–2014 |
| SCHILLER SHAWNself | 3 | 2012–2015 |
| KOWALCZYK JAMES J | 2 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Haverhill, Massachusetts, US | 26 | 2006–2020 |
| Watertown, Massachusetts, US | 3 | 2019–2020 |